Google Ads regularly publishes updates and changes to its many policies. Some of these changes are minor or extremely specific with little effect on most advertisers. Others can be more serious, such as the recent updates by Google to its Healthcare and Medicines policy in July and August 2025. We’ll explain what these recent changes mean, who they affect, and what you may need to do.
What is Google Ad’s Update to its Healthcare and Medicines policy?
At the start of August 2025, Google published a notice that it would be updating its enforcement of the Google Ads Healthcare and Medicines policy. The update stated, “The Restricted Medical Content label, which enables eligible certified advertisers to target prescription drug keywords, will be deprecated.” This label was essential for any advertising products or services with ads that targeted prescription drug keywords.
The update means that Google Ads will no longer be using this label. However, ads targeting prescription drug keywords will still be permitted on the platform. Furthermore, since the label is being deprecated, advertisers will still see it as an available option. However, its deprecation means that Google won’t be internally looking at the label for enforcing its policies around Restricted Drug Terms. In summary, the update means advertisers will simply no longer need to use the “Restricted Medical Content” label on their ads targeting these prescription keywords. Instead, Google will now use its certification system to allow advertisers to target prescription drug keywords.
What is Google Ads’ Restricted Drug Term Personalization Certification?
In July 2025, Google launched a new certification application for advertisers in Canada, as well as the United States and New Zealand, who plan to use Google’s personalized targeting tools to advertise products or services that contain Restricted Drug Terms. Restricted Drug Terms are defined by Google as “prescription medications and information about prescription medications” excluding those that are not prone to abuse/misuse or are strictly for animals. These, by law, cannot normally be generally advertised for personal use. However, prescription medications can be advertised to healthcare professionals in their capacity as medical professionals.
This is where Google Ads’ personalization is potent, since it allows advertisers of these Restricted Drug Terms to specifically target medical professionals. Previously, Google relied on the label to enforce these restrictions. Instead, advertisers will now need to apply and obtain the Restricted Drug Term Personalization Certification. Once received, they can begin running campaigns with Restricted Drug Terms targeted at medical professionals.
Who is Affected by the Changes to Google Ads Medical and Healthcare policies?
The simple answer is anyone targeting restricted drug keywords, i.e. prescription drugs, on Google Ads is affected by the July and August updates. They need to apply for the certification whether they already have campaigns running on the platform or plan to in the coming months. It is best to apply as soon as possible to avoid any disruptions or delays in advertising campaigns on Google. Your marketing agency, like Rosewood Marketing, can apply on your behalf, but they will need a letter authorizing the application. This letter follows a specific format set by Google. Be sure to provide your marketing agency with this letter so that they can apply on your behalf and continue to manage and run your campaigns.
Staying Updated with Google Ads
Now you should have a better idea of the recent changes by Google Ads in its Healthcare and Medicines policy. As mentioned, we recommend applying for the Restricted Drug Term Personalization Certification as soon as possible or providing us with the letter so that we can apply on your behalf. If you’re interested in starting new Google Ads campaigns in this industry, contact our Google ads team, who will be more than happy to lend their expertise.


